Cargando…

Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function

The introduction of novel targeted therapies during the last 2 decades has led to a significant improvement in patients' clinical outcomes with renal cell carcinoma. However, this improvement came at the price of a whole new spectrum of adverse events, including renal toxicity. Systemic treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielczarek, Łukasz, Brodziak, Anna, Sobczuk, Paweł, Kawecki, Maciej, Cudnoch-Jędrzejewska, Agnieszka, Czarnecka, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110505/
https://www.ncbi.nlm.nih.gov/pubmed/33768301
http://dx.doi.org/10.1007/s00280-021-04260-y